Startseite Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status

  • Simplice Harquin Foyet , Ioana-Miruna Balmus , Ngatanko Abaïssou Hervé Hervé , Asongalem Acha Emmanuel , Samson Guenne , Martin Kiendrebéogo und Alin Ciobica EMAIL logo
Veröffentlicht/Copyright: 9. März 2017
Journal of Complementary and Integrative Medicine
Aus der Zeitschrift Journal of Complementary and Integrative Medicine Band 14 Heft 2

Abstract

Neurodegenerative diseases and psychiatric disorders are one of the most important pathologies that lead to increased morbidity in populations. Both mood and anxiety disorders include mental disorders not caused by detectable organic abnormalities of the brain. At the molecular level, affective spectrum symptomatology is due to neurotransmitter dysregulation including receptor or transporter impairments and also due to faulty intracellular signaling that generally leads to impaired neurotransmission. Also, recent studies have shown the relationship between oxidative stress and the development of affective disorders. Since classical medication can cause major side effects and alternative approaches tend to be more and more trusted, it seems that plant extracts-based complementary therapies may offer superior yielding and safety compared to traditional medication.

Keywords: antioxidant enzymes; anxiety; depression; panic disorder; plant extracts

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Ioana-Miruna Balmus was co-funded by the European Social Fund through Sectorial Operational Program of Human Resources Development 2007 – 2013, project number POSDRU/187/1.5/S/155397, project title “Towards a New Generation of Elite Researchers through Doctoral Scholarships” during the work for this review. Ciobica Alin and Miruna Balmus are supported by a PN II Research Grant no. PN-II-RU-TE-2014-4-1886, called “A Complex Study regarding the Relevance of Oxytocin Administration in Some Animal Models of Neuropsychiatric Disorders.”

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Mohamed I, Shuid A, Borhanuddin H, Fozi N. The application of phytomedicine in modern drug development. Int J Herb Plant Med. 2012;1:1–9.10.1155/2012/250584Suche in Google Scholar

2. Payyappallimana U. Role of traditional medicine in primary health care: an overview of perspectives and challenges. Yokohama J Soc Sci. 2010;14:57–77.Suche in Google Scholar

3. Pilania M, Bairwa M, Kumar N, Khanna P, Kurana H. Elderly depression in India: an emerging public health challenge. Australas Med J. 2013;6:107–111.10.4066/AMJ.2013.1583Suche in Google Scholar PubMed PubMed Central

4. World Health Organization. Neurological disorders affect millions globally report. Brussels/Geneva: World Health Organization, 2007.Suche in Google Scholar

5. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2007;62:617–627.10.1001/archpsyc.62.6.617Suche in Google Scholar PubMed PubMed Central

6. Sobocki P, Jönsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9:87–98.10.1016/S1098-3015(10)63569-3Suche in Google Scholar

7. Sylvie DD, Pieme CA, Biapa PC, Penlap BV. Comparison of in vitro antioxidant properties of extracts from three plants used for medical purpose in Cameroon: Acalypha racemosa, Garcinia lucida and Hymenocardia lyrata. Asian Pac J Trop Biomed. 2014;4–2 . S625–S632.10.12980/APJTB.4.201414B168Suche in Google Scholar

8. Xu Y, Wang C, Klabnik JJ, O’Donnell JM. Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment. Cur Neuropharmacol. 2014;12:108–119.10.2174/1570159X11666131120231448Suche in Google Scholar PubMed PubMed Central

9. Trebatická J, Ďuračková Z. Psychiatric disorders and polyphenols: Can they be helpful in therapy?. Oxid Med Cell Longev. 2005;248529.10.1155/2015/248529Suche in Google Scholar PubMed PubMed Central

10. Halliwell B, Lee CY. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signaling. 2010;13:145–156.10.1089/ars.2009.2934Suche in Google Scholar PubMed

11. Halliwell B. Free radicals and antioxidants – quo vadis?. Trends Pharmacol Sci. 2011;32:125–130.10.1016/j.tips.2010.12.002Suche in Google Scholar PubMed

12. Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res. 2010;68:261–27.10.1016/j.neures.2010.08.007Suche in Google Scholar PubMed

13. Akiskal HS. Mood disorders: clinical features. In: Kaplan HI, Sadock BJ, Sadock VA, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry. Philadelphia, PA: Wolters Kluwer: Lippincott Williams & Wilkins, 2004:1.Suche in Google Scholar

14. Wilhelm K, Roy K. Gender differences in depression risk and coping factors in a clinical sample. Acta Psychiatr Scandinav. 2003;106:45–53.10.1034/j.1600-0447.2002.02094.xSuche in Google Scholar PubMed

15. Fišar K, Hroudová J, Raboch J. Neurotransmission in mood disorders. In: Juruena MF, editors. Clinical research and treatment approaches to affective disorders. Rijeka: InTechOpen, 2012:47.10.5772/31831Suche in Google Scholar

16. Evans DL, Charney DS, Lewis IL, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58:175–189.10.1016/j.biopsych.2005.05.001Suche in Google Scholar PubMed

17. Li X, Frye MA, Shelton RC. Mood disorders. Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacol Rev. 2012;37:77–101.10.1038/npp.2011.198Suche in Google Scholar

18. Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2003;14:609–625.10.1038/nrn3381Suche in Google Scholar

19. Angst J, Ajdacic-Gross V, Rössler W. Classification of mood disorders. Psychiatr Pol. 2015;49:663–671.10.12740/PP/58259Suche in Google Scholar

20. Chang CC, Jou SH, Lin TT, Lai TT, Liu CS. Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder. Plos One. 2015;10:0125855.10.1371/journal.pone.0125855Suche in Google Scholar

21. Vaváková M, Ďuračková Z, Trebatická J. Markers of oxidative stress and neuroprogression in depression disorder. Oxid Med Cell Longev 2015 . ID 898393.10.1155/2015/898393Suche in Google Scholar

22. Silva MCC, De Sousa CNS, Gomes PXL, De Oliveira GV, Araújo FYR, Ximenes NC, et al. Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice. Prog Neuro-Psychopharmacol Biol Psych. 2016;64:142–148.10.1016/j.pnpbp.2015.08.002Suche in Google Scholar

23. Fuchs E, Flügge G. Adult neuroplasticity: more than 40 years of research. Neural Plast. 2014;541870.10.1155/2014/541870Suche in Google Scholar

24. Ditzen C, Jastorff AM, Keßler MS, Bunck M, Teplytska L, Erhardt A, et al. Protein biomarkers in a mouse model of extremes in trait anxiety. Mol Cell Proteomics. 2006;5:1914–1920.10.1074/mcp.M600088-MCP200Suche in Google Scholar

25. Siwek M, Sowa-Kuæma M, Dudek D, Styczeñ K, Szewczyk B, Kotarska K, et al. Oxidative stress markers in affective disorders. Pharmacol Rep. 2013;65:1558–1571.10.1016/S1734-1140(13)71517-2Suche in Google Scholar

26. Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies. CNS Drugs. 2013;27:207–219.10.1007/s40263-013-0044-3Suche in Google Scholar PubMed

27. Ďuračková Z. Some current insights into oxidative stress. Physiol Res. 2010;59:459–469.10.33549/physiolres.931844Suche in Google Scholar PubMed

28. Salim S. Oxidative stress and psychological disorders. Cur Neuropharmacol. 2014;12:140–147.10.2174/1570159X11666131120230309Suche in Google Scholar PubMed PubMed Central

29. Luca M, Luca A, Calandra C. Accelerated aging in major depression: the role of nitro-oxidative stress. Oxid Med Cell Longev 2013 . ID 230797.10.1155/2013/230797Suche in Google Scholar PubMed PubMed Central

30. Gautam M, Agrawal M, Gautam M, Sharma A, Gautam A, Gautam M. Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry. 2012;54:244–247.10.4103/0019-5545.102424Suche in Google Scholar PubMed PubMed Central

31. Bulut M, Selek S, Bez Y, Karababa YA, Kaya MC, et al. Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder. J Affect Disord. 2013;150:829–833.10.1016/j.jad.2013.03.011Suche in Google Scholar PubMed

32. Bouayed J, Rammal H, Younos C, Soulimani R. Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice. Eur J Pharmacol. 2007;564:146–149.10.1016/j.ejphar.2007.02.055Suche in Google Scholar PubMed

33. Masood A, Nadeem A, Mustafa SJ, O’Donnell JM. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther. 2008;326:369–379.10.1124/jpet.108.137208Suche in Google Scholar PubMed PubMed Central

34. Ranjana SK, Reena N, Deepti P, Shruti K, Hari KD. Markers of oxidative stress in generalized anxiety psychiatric disorder: therapeutic implications. J Stress Physiol Biochem. 2012;8:32–38.Suche in Google Scholar

35. Hassan W, Silva CEB, Mohammadzai IU, Da Rocha JTB, Landeira-Fernandez J. Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions. Cur Neuropharmacol. 2014;12:120–139.10.2174/1570159X11666131120232135Suche in Google Scholar PubMed PubMed Central

36. Berry A, Capone F, Giorgio M, Pelicci PG, De Kloet ER, Alleva E, et al. Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice. Exp Gerontol. 2007;42:37–45.10.1016/j.exger.2006.05.018Suche in Google Scholar PubMed

37. Ersoy M, Salek K, Celik H, Erel O, Kaya MC, Savas HA. Role of oxidative and antioxidative parameters in ethiopathogenesis and prognosis of panic disorder. Int J Neurosci. 2008;118:1025–1037.10.1080/00207450701769026Suche in Google Scholar PubMed

38. Cengiz M, Bayoglu B, Alansal NO, Cengiz S, Dirican A, Kocabasoglu N. Pro198Leu polymorphism in the oxidative stress gene, glutathione peroxidase-1, is associated with a gender-specific risk for panic disorder. Int J Psychiatry Clin Pract. 2015;2:1–7.10.3109/13651501.2015.1016973Suche in Google Scholar PubMed

39. Lissemore JI, Leyton M, Gravel P, Sookman D, Nordahl TE, Benkelfat C PET and SPECT in Psychiatry. In: Rajo D, et al., editors. OCD: Serotonergic mechanisms. Berlin: Springer, 2014:433–450.10.1007/978-3-642-40384-2_17Suche in Google Scholar

40. Orhan N, Kucukali CI, Cakir U, Seker N, Aydin M. Genetic variants in nuclearencoded mitochondrial proteins are associated with oxidative stress in obsessive compulsive disorders. J Psychiat Res. 2012;46:212e8.10.1016/j.jpsychires.2011.09.012Suche in Google Scholar PubMed

41. Behl A, Swami G, Sircar SS, Bhatia MS, Banerjee BD. Relationship of possible stress related biochemical markers to oxidative/antioxidative status in obsessive compulsive disorder. Neuropsychobiology. 2010;61:210e4.10.1159/000306591Suche in Google Scholar PubMed

42. Selek S, Herken H, Bulut M, Ceylan MF, Celik H, Savas HA, et al. Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidantantioxidant status. Prog Neuro-Psychopharmacol Biol Psych. 2008;32:487e91.10.1016/j.pnpbp.2007.10.002Suche in Google Scholar PubMed

43. Kandemir H, Abuhandan M, Aksoy N, Savik E, Kaya C. Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. J Psychiatr Res. 2013;47:1831e1834.10.1016/j.jpsychires.2013.08.010Suche in Google Scholar PubMed

44. Krolow R, Arcego DM, Noschang C, Weis SN, Dalmaz C. Oxidative imbalance and anxiety disorders. Cur Neuropharmacol. 2014;12:193–204.10.2174/1570159X11666131120223530Suche in Google Scholar PubMed PubMed Central

45. Martin A, Chalder T, Rief W, Braehler E. The relationship between chronic fatigue and somatization syndrome: a general population survey. J Psychosom Res. 2007;63:147–156.10.1016/j.jpsychores.2007.05.007Suche in Google Scholar PubMed

46. Sindhi V, Gupta V, Sharma K, Bhatnagar S, Kumari R, Dhaka N. Potential applications of antioxidants. A review. J Pharm Res. 2013;7:828–835.10.1016/j.jopr.2013.10.001Suche in Google Scholar

47. Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis. 2008;15:473–493.10.3233/JAD-2008-15314Suche in Google Scholar PubMed PubMed Central

48. Li X, Deng J, Shen S, Li T, Yuan M, Yang R, et al. Antioxidant activities and functional properties of enzymatic protein hydrolysates from defatted Camellia oleifera seed cake. J Food Sci Technol. 2015;52:5681–5690.10.1007/s13197-014-1693-zSuche in Google Scholar PubMed PubMed Central

49. Mut-Salud N, Álvarez PJ, Garrido JM, Carrasco E, Aránega A, Rodríguez-Serrano F. Antioxidant intake and antitumor therapy: toward nutritional recommendations for optimal results. Oxid Med Cell Longev. 2016;6719534.10.1155/2016/6719534Suche in Google Scholar PubMed PubMed Central

50. Foyet HS, Hritcu L, Ciobica A, Stefan M, Kamtchouing P, Cojocaru D. Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease. J Ethnopharmacol. 2011;133:773–779.10.1016/j.jep.2010.11.011Suche in Google Scholar PubMed

51. Hritcu L, Ciobica A, Artenie V. Effects of right-unilateral 6-hydroxydopamine infusion-induced memory impairment and oxidative stress: relevance for Parkinson’s disease. Cent Eur J Biol. 2008;3:250–257.10.2478/s11535-008-0023-8Suche in Google Scholar

52. Foyet HS, Tsala DE, Bouba AA, Hritcu L. Anxiolytic and antidepressant-like effects of the aqueous extract of Alafia multiflora stem barks in rodents. Adv Pharmacol Sci 2012 . ID 912041.10.1155/2012/912041Suche in Google Scholar PubMed PubMed Central

53. Foyet HS, Ngatanko Abaïssou HH, Wado E, Asongalem Acha E, Ciobica A. Emilia coccinea (SIMS) G extract improves memory impairment, cholinergic dysfunction, and oxidative stress damage in scopolamine-treated rats. BMC Complement Altern Med. 2015;15:333.10.1186/s12906-015-0864-4Suche in Google Scholar PubMed PubMed Central

54. Crupi R, Mazzon E, Marino A, La Spada G, Bramanti P, Battaglia F, et al. Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice. BMC Complement Altern Med. 2011;11:7.10.1186/1472-6882-11-7Suche in Google Scholar PubMed PubMed Central

55. Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006;13:607–611.10.1016/j.phymed.2006.08.006Suche in Google Scholar PubMed

56. Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21:841–860.10.1016/j.euroneuro.2011.04.002Suche in Google Scholar PubMed

57. Pereira RP, Fachinetto R, De Souza Prestes A, Puntel RL, Santos Da Silva GN, Heinzmann BM, et al. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem Res. 2009;34:973–983.10.1007/s11064-008-9861-zSuche in Google Scholar PubMed

58. Singh V, Singh PS, Chan K. Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia. Int J Neuropsychopharmacol. 2010;13:257–271.10.1017/S1461145709990654Suche in Google Scholar PubMed

59. Lohani M, Ahuja M, Buabeid MA, Dean S, Dennis S, Suppiramaniam V, et al. Anti-oxidative and DNA protecting effects of flavonoids-rich Scutellaria lateriflora. Nat Prod Commun. 2013;8:1415–1418.10.1177/1934578X1300801019Suche in Google Scholar

60. Sayyah M, Boostani H, Pakseresht S, Malayeri A. Comparison of Silybum marianum (L) Gertn with fluoxetine in the treatment of obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psych. 2010;34:362–365.10.1016/j.pnpbp.2009.12.016Suche in Google Scholar

61. Herman H, Pilat L, Mihali C, Popescu C, Turcus V, Ardelean A, et al. Pharmacology of Silybum marianum and its active constituents. Therapeutic activity – Part 2. Arad Med J. 2011;14:35–40.Suche in Google Scholar

62. Elsas SM, Rossi DJ, Raber J, White G, Seeley CA, Gregory WL, et al. Passiflora incarnata L. (Passion flower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010;17:940–949.10.1016/j.phymed.2010.03.002Suche in Google Scholar

63. Chen Y, Han T, Qin L, Rui Y, Zheng H. Effect of total triterpenes from Centella asiatica on the depression behavior and concentration of amino acid in forced swimming mice. Zhong Yao Cai. 2003;26:870–873.Suche in Google Scholar

64. Sepand MR, Soodi M, Hajimehdipoor H, Soleimani H, Sahraei E. Comparison of neuroprotective effects of Melissa officinalis total extract and its acidic and non-acidic fractions against A β-induced toxicity. Iran J Pharmacol Res. 2013;12:415–423.Suche in Google Scholar

65. Ranjbar A, Khorami S, Safarabadi M, Shahmoradi A, Malekirad AA, Vakilian K, et al. Antioxidant activity of Iranian Echium amoenum fisch & C.A. Mey flower decoction in humans: a cross-sectional before/after clinical trial. Evid Based Complement Alternat Med. 2006;3:469–473.10.1093/ecam/nel031Suche in Google Scholar

66. Joshi YB, Praticò D. Lipid peroxidation in psychiatric illness: overview of clinical evidence. Oxid Med Cell Longev 2014 . ID 828702.10.1155/2014/828702Suche in Google Scholar

67. Erdem M, Akarsu S, Pan E, Kurt YG. Bipolar disorder and oxidative stress. Jmood. 2014;4:70–79.10.5455/jmood.20131205063815Suche in Google Scholar

68. Liu T, Zhong S, Liao X, Chen J, He T, et al. A meta-analysis of oxidative stress markers in depression. Plos One. 2015;10:0138904.10.1371/journal.pone.0138904Suche in Google Scholar

69. Thomas SP, Nandhra HS, Jayaraman A. Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD). J Ment Health. 2010;19:168–175.10.3109/09638230903469269Suche in Google Scholar

70. Malhi GS, Tanious M, Das P, Coulston CM, Berk M. Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs. 2013;27:135–153.10.1007/s40263-013-0039-0Suche in Google Scholar

71. Takeda H, Tsuji M, Inazu M, Egashira T, Matsumiya T. Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice. Eur J Pharmacol. 2002;449:261–267.10.1016/S0014-2999(02)02037-XSuche in Google Scholar

72. Hritcu L, Foyet HS, Stefan M, Mihasan M, Asongalem AE, Kamtchouing P. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. J Ethnopharmacol. 2011;137:585–591.10.1016/j.jep.2011.06.008Suche in Google Scholar PubMed

73. Oboh G, Rocha JBT. Antioxidant and neuroprotective properties of sour tea (Hibiscus sabdariffa, calyx) and green tea (Camellia sinensis) on some pro-oxidant-induced lipid peroxidation in brain in vitro. Food Biophys. 2008;3:382–389.10.1007/s11483-008-9092-5Suche in Google Scholar

74. Nade VS, Kanhere SV, Kawale LA, Yadav AV. Cognitive enhancing and antioxidant activity of ethyl acetate soluble fraction of the methanol extract of Hibiscus rosa sinensis in scopolamine induced amnesia. Indian Pharmacol. 2011;43:137–142.10.4103/0253-7613.77347Suche in Google Scholar PubMed PubMed Central

75. Foyet HS, Tsala DE, Ngatanko AH. Enhancing spatial memory: anxiolytic and antidepressant effects of Tapinanthus dodoneifolius (DC) Danser in mice. Neurol Res Int. 2014;974308.10.1155/2014/974308Suche in Google Scholar PubMed PubMed Central

76. Hritcu L, Noumedem JA, Cioanca O, Hancianu M, Postu P, Mihasan M. Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1-42) rat model of Alzheimer’s disease. Behav Brain Funct. 2015;11:13.10.1186/s12993-015-0059-7Suche in Google Scholar PubMed PubMed Central

77. Hritcu L, Cioanca O, Hancianu M. Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine. 2012;19:529–534.10.1016/j.phymed.2012.02.002Suche in Google Scholar PubMed

78. Cioanca O, Hritcu L, Mihasan M, Trifan A, Hancianu M. Inhalation of coriander volatile oil increased anxiolytic-antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1-42) rat model of Alzheimer’s disease. Physiol Behav. 2014;131:68–74.10.1016/j.physbeh.2014.04.021Suche in Google Scholar PubMed

79. Tsala DE, Theophile D, Judith N, Ng N, Penlap BV, Boda M, et al. Screening of Alafia multiflora for antibacterial, antiradical activity and LD50 investigation. Int J Pharmacol. 2007;3:327–333.10.3923/ijp.2007.327.333Suche in Google Scholar

80. Halliwell B. Reactive species and antioxidants. redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006;141:312–322.10.1104/pp.106.077073Suche in Google Scholar PubMed PubMed Central

81. Berk M, Ng F, Dean O, Dodd S, Bush AI. Glutahione: a novel treatment target in psychiatry. Trends Pharmacol Sci. 2008;29:346–351.10.1016/j.tips.2008.05.001Suche in Google Scholar PubMed

82. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11:1–26.10.1017/S1461145707008401Suche in Google Scholar PubMed

83. Pillai A. Brain-derived neurotrophic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia. Neurosignals. 2008;16:183–193.10.1159/000111562Suche in Google Scholar PubMed

84. Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak-the link between depression and cardiovascular disease. Nat Rev Cardiol. 2012;9:526–539.10.1038/nrcardio.2012.91Suche in Google Scholar PubMed

85. Foyet HS, Abdou BA, Ngatanko AH, Manyi FL, Manyo NA, Shu NPN, et al. Neuroprotective and memory improvement effects of a standardized extract of Emilia coccinea (SIMS) G on animal models of anxiety and depression. J Pharmacogn Phytochem. 2014;3:146–154.Suche in Google Scholar

Received: 2016-6-19
Accepted: 2017-1-24
Published Online: 2017-3-9
Published in Print: 2017-3-8

© 2017 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Review
  2. Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status
  3. Preclinical Studies
  4. Cytokine changes in gastric and colonic epithelial cell in response to Planta ovata extract
  5. Preliminary phytochemical analysis and evaluation of antioxidant, cytotoxic and inhibition of lipopolysaccaride - induced NOS (iNOS) expression in BALB/c mice liver by Ziziphus oenoplia Mill. fruit
  6. Evaluation of the sub-chronic toxicity profile of the corm of Xanthosoma sagittifolium on hematology and biochemistry of alloxan-induced diabetic Wistar rats
  7. Dendrobium chrysanthum ethanolic extract induces apoptosis via p53 up-regulation in HeLa cells and inhibits tumor progression in mice
  8. Safety assessment of the aqueous extract of the flowers of Nymphaea lotus Linn (Nymphaeaceae): Acute, neuro- and subchronic oral toxicity studies in albinos Wistar rats
  9. Effect of aqueous extract of Aegle marmelos fruit and leaf on glycemic, insulinemic and lipidemic status of type 2 diabetic model rats
  10. Antihypernociceptive and antioxidant effects of Petersianthus macrocarpus stem bark extracts in rats with complete Freund’s adjuvant-induced persistent inflammatory pain
  11. ROS-mediated induction of apoptosis by benzoquinone embelin in human colon adenocarcinoma cells HT-29
  12. Clinical Studies
  13. Desensitization to chemical and food sensitivities by low-dose immunotherapy ascertained by provocation neutralization is associated with reduced influx of calcium ions into lymphocytes
  14. Managing irritable bowel syndrome: The impact of micro-physiotherapy
  15. Short Communication
  16. Design development and evaluation of triphala tablets
https://doi.org/10.1515/jcim-2016-0059
Schlagwörter für diesen Artikel
antioxidant enzymes; anxiety; depression; panic disorder; plant extracts

Artikel in diesem Heft

  1. Review
  2. Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status
  3. Preclinical Studies
  4. Cytokine changes in gastric and colonic epithelial cell in response to Planta ovata extract
  5. Preliminary phytochemical analysis and evaluation of antioxidant, cytotoxic and inhibition of lipopolysaccaride - induced NOS (iNOS) expression in BALB/c mice liver by Ziziphus oenoplia Mill. fruit
  6. Evaluation of the sub-chronic toxicity profile of the corm of Xanthosoma sagittifolium on hematology and biochemistry of alloxan-induced diabetic Wistar rats
  7. Dendrobium chrysanthum ethanolic extract induces apoptosis via p53 up-regulation in HeLa cells and inhibits tumor progression in mice
  8. Safety assessment of the aqueous extract of the flowers of Nymphaea lotus Linn (Nymphaeaceae): Acute, neuro- and subchronic oral toxicity studies in albinos Wistar rats
  9. Effect of aqueous extract of Aegle marmelos fruit and leaf on glycemic, insulinemic and lipidemic status of type 2 diabetic model rats
  10. Antihypernociceptive and antioxidant effects of Petersianthus macrocarpus stem bark extracts in rats with complete Freund’s adjuvant-induced persistent inflammatory pain
  11. ROS-mediated induction of apoptosis by benzoquinone embelin in human colon adenocarcinoma cells HT-29
  12. Clinical Studies
  13. Desensitization to chemical and food sensitivities by low-dose immunotherapy ascertained by provocation neutralization is associated with reduced influx of calcium ions into lymphocytes
  14. Managing irritable bowel syndrome: The impact of micro-physiotherapy
  15. Short Communication
  16. Design development and evaluation of triphala tablets
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jcim-2016-0059/html
Button zum nach oben scrollen